戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ty with regard to both UDP-galactose and UDP-N-acetylgalactosamine.
2 omplete loss of activity with respect to UDP-N-acetylgalactosamine.
3 pecific lectin and shows little affinity for N-acetylgalactosamine.
4 r substrates UDP-N-acetylglucosamine and UDP-N-acetylgalactosamine.
5  glucose, galactose, N-acetylglucosamine and N-acetylgalactosamine.
6 ne-5'-[P1-32P]triphosphate, an analog of UDP-N-acetylgalactosamine.
7 ose and partially reduced with regard to UDP-N-acetylgalactosamine.
8 ivatives of 2,4-diacetamidobacillosamine and N-acetylgalactosamine.
9 mino sugars, UDP N-acetylglucosamine and UDP N-acetylgalactosamine.
10 N-acetylglucosamine, mannose, galactose, and N-acetylgalactosamine.
11 and was inhibited by N-acetylglucosamine and N-acetylgalactosamine.
12 strate UDP-N-acetylglucosamine or isomer UDP-N-acetylgalactosamine.
13 ctosamine to generate undecaprenyl phosphate-N-acetylgalactosamine.
14 alactose, UDP- N-acetylglucosamine, and UDP- N-acetylgalactosamine.
15 s, characterized by a terminal or sialylated N-acetylgalactosamine.
16 ng glycan ligands that include galactose and N-acetylgalactosamine.
17  three rhamnose residues and a protein-bound N-acetylgalactosamine.
18 ly discriminated for N-acetylglucosamine and N-acetylgalactosamine.
19 mg), N-acetylglucosamine (2.27 nmol/mg), and N-acetylgalactosamine (0.652 nmol/mg).
20    Eight N-acetylglucosamine-1-phosphate and N-acetylgalactosamine-1-phosphate analogs have been synt
21  deficient activity of arylsulfatase B (ASB; N-acetylgalactosamine 4-sulfatase) and the subsequent ac
22 iciency of the enzyme arylsulfatase B (ARSB; N-acetylgalactosamine 4-sulfatase), either innate or acq
23 ermatan sulfate preparations, we showed that N-acetylgalactosamine-4-O-sulfate residues are required
24          CHST8 encodes a Golgi transmembrane N-acetylgalactosamine-4-O-sulfotransferase (GalNAc4-ST1)
25 dentity with HNK-1 sulfotransferase (21.4%), N-acetylgalactosamine-4-O-sulfotransferase 1 (GalNAc-4-S
26 O-sulfotransferase 1 (GalNAc-4-ST1) (24.7%), N-acetylgalactosamine-4-O-sulfotransferase 2 (GalNAc-4-S
27      We have identified and characterized an N-acetylgalactosamine-4-O-sulfotransferase designated de
28                       The sulfatase enzymes, N-acetylgalactosamine-4-sulfatase (arylsulfatase B (ASB)
29 ha-l-iduronidase, iduronate-2-sulfatase, and N-acetylgalactosamine-4-sulfatase that are used for newb
30 ctivity of the enzyme arylsulfatase B (ARSB; N-acetylgalactosamine-4-sulfatase).
31                             Arylsulfatase B (N-acetylgalactosamine-4-sulfatase; ARSB) removes 4-sulfa
32 omal exohydrolase, cleaving sulfate from the N-acetylgalactosamine-4-sulfate (GalNAc-4S) residue at t
33                           We have cloned the N-acetylgalactosamine-4-sulfotransferase (GalNAc-4-ST1,
34 cosamine (4FGlcNAc) and UDP-4-deoxy-4-fluoro-N-acetylgalactosamine (4FGalNAc), were prepared using bo
35 actosamine-6-sulfatase (GALNS, also known as N-acetylgalactosamine-6-sulfatase and GalN6S; E.C. 3.1.6
36  is an autosomal recessive disease caused by N-acetylgalactosamine-6-sulfate sulfatase (GALNS) defici
37 recessive disorder caused by a deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS), a lys
38 recessive disorder caused by a deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS), leadi
39 , glucose, 3-deoxy-D-manno-octulosonic acid, N-acetylgalactosamine, 8-epi-legionaminic acid, phosphat
40 consist mostly of core 1 alpha2,6 sialylated N-acetylgalactosamine, a configuration suspected to prev
41 msen-Friedenreich antigen (galactose beta1-3 N-acetylgalactosamine alpha-), we have found that this l
42         This truncated antigen has the sugar N-acetylgalactosamine alpha-linked to either a serine or
43 t on the presence of multiple O-linked alpha-N-acetylgalactosamine (alpha-GalNAc) determinants.
44 a agglutin (HPA)) with specificity for alpha-N-acetylgalactosamine (alpha-GalNAc), an epitope display
45           The sulfate portions of 4-sulfated-N-acetylgalactosamine and an unidentified ligand found i
46 Forssman (Fs) antigen terminates with alpha3-N-acetylgalactosamine and can be used by pathogens as a
47 responsible for the uptake and metabolism of N-acetylgalactosamine and galactosamine in Escherichia c
48 mouse DBP carries a disaccharide composed of N-acetylgalactosamine and galactose.
49 useful for the synthesis of [32P]5-azido-UDP-N-acetylgalactosamine and high-specific-activity [3H] or
50 ally acetylated 1-->4 glycosidic linkages of N-acetylgalactosamine and N-acetylglucosamine.
51 cNAc translocator has lower affinity for UDP-N-acetylgalactosamine and UDP-glucose than for its cogna
52 rmer can catalyze the interconversion of UDP-N-acetylgalactosamine and UDP-N-acetylglucosamine while
53 rpart, mammalian GALE also interconverts UDP-N-acetylgalactosamine and UDP-N-acetylglucosamine.
54 terconverts a larger pair of substrates: UDP-N-acetylgalactosamine and UDP-N-acetylglucosamine.
55 DP-galactose and UDP-glucose, as well as UDP-N-acetylgalactosamine and UDP-N-acetylglucosamine.
56 omeric monosaccharides, N-acetylglucosamine, N-acetylgalactosamine, and N-acetylmannosamine.
57 taining the addition of phosphoethanolamine, N-acetylgalactosamine, and N-acetylneuraminic acid.
58 affinity purified on immobilized lactose and N-acetylgalactosamine, and N-glycosylated but not glycos
59 g SQV-7 transported UDP-glucuronic acid, UDP-N-acetylgalactosamine, and UDP-galactose (Gal) in a temp
60 ive form of LD, express a unique glycan with N-acetylgalactosamine as a terminal sugar.
61 -N-acetylglucosamine or uridine 5'-diphospho-N-acetylgalactosamine as substrates but will accept urid
62  However, the enzyme preferentially utilized N-acetylgalactosamine as the donor for all three accepto
63 s that bear uronic acid linked to unsulfated N-acetylgalactosamine as the initial disaccharide in the
64 macrophage activating factor, a protein with N-acetylgalactosamine as the remaining sugar moiety.
65 otein (DBP) to yield the MAF, a protein with N-acetylgalactosamine as the remaining sugar.
66 , including fucose, N-acetylglucosamine, and N-acetylgalactosamine as well as the yeast polysaccharid
67 f Cys-MR alone and complexed with 4-sulfated-N-acetylgalactosamine at 1.7 and 2.2 A resolution, respe
68     Phosphorylated O-mannosyl trisaccharide [N-acetylgalactosamine-beta3-N-acetylglucosamine-beta4-(p
69 gest that it is a good model for the natural N-acetylgalactosamine binding site of the asialoglycopro
70 ca cleaves cell surface galactose-binding or N-acetylgalactosamine-binding (Gal/Gal-NAc) lectins.
71 oprotein reporter showed that it transferred N-acetylgalactosamine, but no detectable galactose or N-
72  showed that the purified enzyme transferred N-acetylgalactosamine, but no detectable galactose or N-
73 pwise fashion beginning with the addition of N-acetylgalactosamine by the enzyme N-acetylgalactosamin
74 CRD displays 40-fold preferential binding to N-acetylgalactosamine compared with galactose, making it
75 4-fold increase in the relative affinity for N-acetylgalactosamine compared with galactose.
76 tin family, displays preferential binding to N-acetylgalactosamine compared with galactose.
77 /kg or 4 mg/kg RG-101, a hepatocyte targeted N-acetylgalactosamine conjugated anti-miR-122 oligonucle
78 single dose of RG-101, a hepatocyte targeted N-acetylgalactosamine conjugated oligonucleotide that an
79                    Treatment with RG-101, an N-acetylgalactosamine-conjugated anti-microRNA-122 oligo
80 d, followed 24 hours later by a biotinylated N-acetylgalactosamine-containing "clearing agent" and fi
81 administered sequentially with a dendrimeric N-acetylgalactosamine-containing clearing agent and radi
82 streptavidin (SA) conjugates, followed by an N-acetylgalactosamine dendrimeric clearing agent and rad
83 oglycan consisting of repeating uronic acid, N-acetylgalactosamine disaccharide units {[HexAbeta/alph
84 ansporter of UDP-N-acetylglucosamine and UDP-N-acetylgalactosamine encoded by the Caenorhabditis eleg
85  of a melittin-derived peptide conjugated to N-acetylgalactosamine for hepatocyte targeting and endos
86 he first enzyme required for biosynthesis of N-acetylgalactosamine, for the major cyst wall polysacch
87 The Fml adhesin FmlH binds galactose beta1-3 N-acetylgalactosamine found in core-1 and -2 O-glycans.
88 transfer reaction of N-acetylglucosamine and N-acetylgalactosamine from the respective UDP-sugars to
89  glycans by catalyzing the transfer of alpha-N-acetylgalactosamine from UDP-GalNAc to Ser or Thr resi
90 . parvum sporozoites to the sugar, galactose-N-acetylgalactosamine (Gal/GalNAc), and to bovine mucin
91 vine DBP carries a trisaccharide composed of N-acetylgalactosamine, galactose, and sialic acid, where
92 O-glycosidase that cleaves galactose beta1-3 N-acetylgalactosamine (Galbeta1-3GalNAc) from core-1 O-l
93 antigen is a disaccharide, galactose beta1-3 N-acetylgalactosamine (Galbeta1-3GalNAc), expressed on t
94 t WbiP could readily glycosylate a series of N-acetylgalactosamine (GalNAc) analogues with alpha-subs
95  produce a polysaccharide capsule containing N-acetylgalactosamine (GalNAc) and beta-3-deoxy-d-manno-
96 hat tx5a contains a disaccharide composed of N-acetylgalactosamine (GalNAc) and galactose (Gal), but
97 r residues: one fucose (Fuc) and two each of N-acetylgalactosamine (GalNAc) and galactose (Gal).
98 ate production of both UDP-galactose and UDP-N-acetylgalactosamine (GalNAc) and is required for the p
99 vine reproductive tract mucins, and terminal N-acetylgalactosamine (GalNAc) and sulfated carbohydrate
100      Chemical analyses confirmed the loss of N-acetylgalactosamine (GalNAc) and the presence of NeuNA
101  this protocol, N-acetylglucosamine (GlcNAc)/N-acetylgalactosamine (GalNAc) are phosphorylated by N-a
102 aloglycoprotein receptor ligand derived from N-acetylgalactosamine (GalNAc) facilitates targeted deli
103 biosynthesis is initiated by the transfer of N-acetylgalactosamine (GalNAc) from a nucleotide sugar d
104 y occurring glycoconjugate motifs containing N-acetylgalactosamine (GalNAc) from the cheaper and comm
105 omopolymer: chitin in Entamoeba and a unique N-acetylgalactosamine (GalNAc) homopolymer in Giardia.
106    We found that not only galactose but also N-acetylgalactosamine (GalNAc) is an efficient competito
107 at recognizes the sugars galactose (Gal) and N-acetylgalactosamine (GalNAc) on the surface of host ce
108 es, like FS, catalyze the addition of either N-acetylgalactosamine (GalNAc) or galactose (Gal) in alp
109 a 1-->3 glycosidic linkage to the core alpha-N-acetylgalactosamine (GalNAc) residue.
110 nked to the BclA protein backbone through an N-acetylgalactosamine (GalNAc) residue.
111 taining IgA1 and IgG antibodies specific for N-acetylgalactosamine (GalNAc) residues in O-linked glyc
112 als 61% (range, 12-95%) of the peptide alpha-N-acetylgalactosamine (GalNAc) residues to be substitute
113 t complexed with beta-methyl galactoside and N-acetylgalactosamine (GalNAc) reveal that as with wild-
114 tive transfers of glucoronic acid (GlcA) and N-acetylgalactosamine (GalNAc) to elongate a chain consi
115  O glycosylation is initiated by polypeptide N-acetylgalactosamine (GalNAc) transferase (ppGalNAcT) a
116        Our knowledge of the O-glycoproteome [N-acetylgalactosamine (GalNAc) type] is highly limited.
117 ine (GlcNAc), galactose (Gal), xylose (Xyl), N-acetylgalactosamine (GalNAc), and glucose (Glc), using
118 ed glycosylation containing galactose (Gal), N-acetylgalactosamine (GalNAc), and sialic acid.
119 minopeptidase N is specifically inhibited by N-acetylgalactosamine (GalNAc), suggesting that this tox
120 es, as demonstrated by the implementation of N-acetylgalactosamine (GalNAc)-conjugated ASOs for Asial
121 ed silencing in the context of the trivalent N-acetylgalactosamine (GalNAc)-conjugated siRNA in mice
122       Certain lectins recognize the terminal N-acetylgalactosamine (GalNAc)-containing O-glycans on G
123 ringiensis strains) lacked Gal and contained N-acetylgalactosamine (GalNAc).
124 arides that are modified with beta1,4-linked N-acetylgalactosamine (GalNAc).
125 family of uridine 5'-diphosphate (UDP)-alpha-N-acetylgalactosamine (GalNAc):polypeptide N-acetylgalac
126 proteins bearing terminal galactose (Gal) or N-acetylgalactosamine (GalNAc); however, endogenous liga
127                                  Mucin-type (N-acetylgalactosamine [GalNAc]-type) O-glycosylation is
128              A series of sialyl fucosyl poly-N-acetylgalactosamine gangliosides without the sialyl-Le
129 Globoside or P antigen is synthesized by UDP-N-acetylgalactosamine:globotriaosyl-ceramide 3-beta-N-ac
130 ood group criteria and is synthesized by UDP-N-acetylgalactosamine: globotriaosylceramide 3-beta-N-ac
131  the gene for GM2/GD2 synthase [GalNAcT (UDP-N-acetylgalactosamine:GM3/GD3 beta-1,4-N-acetylgalactosa
132 wth, galactosamine, N-acetylglucosamine, and N-acetylgalactosamine had no significant effect on the p
133 ein, a fourth region likely to interact with N-acetylgalactosamine has been identified and probed by
134 he structural basis for selective binding to N-acetylgalactosamine has been investigated.
135 d to be important in preferential binding to N-acetylgalactosamine have been inserted into the homolo
136 s transferred sulfate to the C-4 position of N-acetylgalactosamine in chondroitin and desulfated derm
137 ne a binding pocket for the 2-substituent of N-acetylgalactosamine in the hepatic asialoglycoprotein
138 -acetylhexosamine (HexNAc), either GlcNAc or N-acetylgalactosamine, in the terminal position or, alte
139 eglycosylated CD44 enhanced binding; and (d) N-acetylgalactosamine incorporation into non-N-linked gl
140 t is completely inhibited in the presence of N-acetylgalactosamine, indicating loss of domain III bin
141 teins was identified as the 170-kD galactose/N-acetylgalactosamine-inhibitable lectin (Gal/GalNAc) us
142  not galactosamine, N-acetylglucosamine, and N-acetylgalactosamine inhibited the growth of the parasi
143 mediate, and light subunits of the galactose-N-acetylgalactosamine-inhibitible lectin, an important c
144 s changed to valine, loss in selectivity for N-acetylgalactosamine is observed.
145 te residues in combination with 4-O-sulfated N-acetylgalactosamine is sufficient for high affinity bi
146  by yeast hexokinase, homoserine kinase, and N-acetylgalactosamine kinase (obtained by comparison of
147 he transition state were 2.1 x 10(-16) m for N-acetylgalactosamine kinase, 7.4 x 10(-17) m for homose
148 d using 5-azido-UTP, [gamma-32P]ATP, porcine N-acetylgalactosamine kinase, and Escherichia coli UDP-N
149  N-acetylglucosamine and uridine diphosphate N-acetylgalactosamine, leading to the synthesis of epime
150                         Fecal anti-galactose/N-acetylgalactosamine lectin immunoglobulin A was associ
151 ducible nitric oxide synthase, and galactose/N-acetylgalactosamine macrophage lectin, as well as TGF-
152 alNAc unit, suggesting that 4-O-sulfation at N-acetylgalactosamine may precede epimerization of glucu
153  initiates docking through recognition of an N-acetylgalactosamine moiety on L. dispar APN.
154 ng galactose, glucose, sialic acid, mannose, N-acetylgalactosamine, N-acetylglucosamine, and fucose.
155 de with the terminal galactose replaced with N-acetylgalactosamine (NHAc-Pk).
156 ation, O-linked mannose (O-Man) and O-linked N-acetylgalactosamine (O-GalNAc), in its highly conserve
157  Ser/Thr-O-GlcNAc, alpha-linked Ser-O-linked N-acetylgalactosamine (O-GalNAc), or N-linked oligosacch
158 a mucin-related O-linked glycopeptide, alpha-N-acetylgalactosamine-O-serine/threonine (Tn), which is
159  analogue PPA15(T7), glycosylated with alpha-N-acetylgalactosamine on Thr7, were prepared and investi
160 vent have lost the ability to utilize either N-acetylgalactosamine or galactosamine as sole sources o
161 ers had elevated activity in the presence of N-acetylgalactosamine or galactosamine, were regulated i
162            Enzymatic removal of the terminal N-acetylgalactosamine or galactose of A- or B-antigens,
163 t binds to glycoproteins expressing terminal N-acetylgalactosamine or galactose residues.
164 ptor (a structure terminated with galactose, N-acetylgalactosamine, or sialic acid).
165 samine but not by galactose, xylose, fucose, N-acetylgalactosamine, or sialic acid-containing glycopr
166 actions appear to produce the preference for N-acetylgalactosamine over galactose and are also likely
167 e essential for establishing selectivity for N-acetylgalactosamine over galactose.
168  by distinct recombinant uridine diphosphate-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyl
169 ptides over Ser peptides for the porcine UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyl
170 the ability to synthesize polyprenyl-phospho-N-acetylgalactosamine (polyprenyl-P-GalNAc) from polypre
171  in complex with the N-acetylglucosamine and N-acetylgalactosamine products of catalysis and in compl
172 cate the existence of another galactose- and N-acetylgalactosamine-recognizing lectin distinct from m
173 isplay stronger binding to galactosamine and N-acetylgalactosamine relative to d-galactose.
174 -linked oligosaccharides containing terminal N-acetylgalactosamine required for [125I]Cry1Ac binding
175 , the core of these glycans is frequently an N-acetylgalactosamine residue that is alpha-linked to se
176 the interaction of the peptide and the first N-acetylgalactosamine residue.
177 l exoglycosidase that cleaves terminal alpha-N-acetylgalactosamine residues from glycopeptides and gl
178        Each cleaved nonreducing alpha(1-->3)-N-acetylgalactosamine residues from human blood group A
179 ient in patients with IgAN, leaving terminal N-acetylgalactosamine residues in the hinge region expos
180 eceptor binds oligosaccharides with terminal N-acetylgalactosamine residues more tightly than ligands
181 on of bulky substituents to the reducing end N-acetylgalactosamine residues of C4S dodecasaccharide h
182 The epitope recognized by 4E9 contains alpha-N-acetylgalactosamine residues, which are present in a m
183  is a result of the presence of alpha-linked N-acetylgalactosamine residues.
184 for determination of the sulfate position on N-acetylgalactosamine residues.
185 their glycan components contain alpha-linked N-acetylgalactosamine residues.
186 bohydrate-recognition domain in complex with N-acetylgalactosamine reveals a direct interaction betwe
187 report that metabolic cross-talk between the N-acetylgalactosamine salvage and O-GlcNAcylation pathwa
188 as good as or better than that of the parent N-acetylgalactosamine, showing that modification on eith
189  for the rat Kupffer cell lectin (fucose and N-acetylgalactosamine specific) adhered specifically to
190 sferase was significantly lower, and that of N-acetylgalactosamine-specific alpha2,6-sialyltransferas
191 tosyltransferase activity and an increase in N-acetylgalactosamine-specific alpha2,6-sialyltransferas
192 yltransferase or a terminal sialic acid by a N-acetylgalactosamine-specific alpha2,6-sialyltransferas
193 known as the mouse macrophage galactose- and N-acetylgalactosamine-specific lectin (mMGL).
194  either patent or latent reactivity with the N-acetylgalactosamine-specific lectin Vicia villosa aggl
195 the neutralizing effect of the MAb and alpha-N-acetylgalactosamine-specific lectins strongly implicat
196 hydrate units that terminate with a sulfated N-acetylgalactosamine structure (GalNAc-4-SO(4)) that me
197 ecific for either N-acetylneuraminic acid or N-acetylgalactosamine, suggesting that it was composed o
198 oglycan consisting of repeating uronic acid, N-acetylgalactosamine sulfate disaccharide units [-UroA(
199 ctrophoresis analysis demonstrated increased N-acetylgalactosamine sulfation at both 4- and 6-carbons
200 lectins specifically recognize galactose- or N-acetylgalactosamine-terminated oligosaccharides.
201 ystal structure of the modified CRD bound to N-acetylgalactosamine, the histidine (His(202)) contacts
202 for the discrimination between galactose and N-acetylgalactosamine, the substrate transferred by GTA.
203 lls convert added peracetylated benzyl-alpha-N-acetylgalactosamine to a large variety of modified O-g
204 nkages joining either N-acetylglucosamine or N-acetylgalactosamine to a wide variety of aglycon resid
205 se structures showed N-acetylglucosamine and N-acetylgalactosamine to be recognized via identical set
206 nsferred galactose, N-acetylglucosamine, and N-acetylgalactosamine to carbohydrate, glycoprotein, and
207 ndensation of undecaprenyl phosphate and UDP-N-acetylgalactosamine to generate undecaprenyl phosphate
208  arabinose, fucose, methyl galacturonate and N-acetylgalactosamine to give the corresponding peracety
209 binant EXTL2 showed weak ability to transfer N-acetylgalactosamine to heparan sulfate precursor molec
210 modification of glycans by beta4 addition of N-acetylgalactosamine to N-acetylglucosamine with format
211 tro incorporation of N-acetylglucosamine and N-acetylgalactosamine to oligosaccharide acceptors resem
212 gainst Anln messenger RNA were conjugated to N-acetylgalactosamine to reduce toxicity and increase he
213                              The addition of N-acetylgalactosamine to Ser71, Thr72, Thr75, and Thr139
214 the acetyl group from undecaprenyl phosphate-N-acetylgalactosamine to yield undecaprenyl phosphate-be
215  synthase K4CP catalyzes glucuronic acid and N-acetylgalactosamine transfer activities and polymerize
216 r sequence abolishes glucuronic acid but not N-acetylgalactosamine transfer activity in K4CP.
217                              The polypeptide N-acetylgalactosamine transferase-1 (ppGalNAcT-1) initia
218 oplasmic reticulum relocation of polypeptide N-acetylgalactosamine-transferases (GalNAc-Ts) drives hi
219 nd purified the rat liver Golgi membrane UDP-N-acetylgalactosamine transporter.
220                        Here we show that the N-acetylgalactosamine-type O-glycosylation enzyme GALNT1
221 otein, shows UDP-GlcNAcA 4-epimerase and UDP-N-acetylgalactosamine (UDP-GalNAc) 4-epimerase activitie
222 UDP-N-acetylglucosamine (UDP-GlcNAc) and UDP-N-acetylgalactosamine (UDP-GalNAc) transport in Arabidop
223 0 ratio of UDP-GlcNAc to uridine diphosphate-N-acetylgalactosamine (UDP-GalNAc), irrespective of the
224 d-type transporter, whereas transport of UDP-N-acetylgalactosamine was decreased by 85-90%, resulting
225 VPTTST(GalNAc)TSAP (where GalNAc is O-linked N-acetylgalactosamine), were shown to coelute following
226 es, composed mainly of galacturonic acid and N-acetylgalactosamine, were characterised for the first
227 ased on these results and the orientation of N-acetylgalactosamine when bound to an homologous galact
228 -2, however, did not form 4, 6-di-O-sulfated N-acetylgalactosamine when chondroitin sulfate C was use
229 d on Thr(402) with an N-acetylglucosamine or N-acetylgalactosamine, whereas Ser(692) remained unmodif
230 G), which inhibit membrane interactions, and N-acetylgalactosamine, which targets asialoglycoprotein
231                                              N-Acetylgalactosamine yielded two major peaks, which wer

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top